Mirae Asset Global Etfs Holdings »

Acelyrin shares owned by Mirae Asset Global Etfs Holdings

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Mirae Asset Global Etfs Holdings from 13F filings

Historical chart of Mirae Asset Global Etfs Holdings investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Mirae Asset Global Etfs Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Mirae Asset Global Etfs Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $198k 40k 4.93
2024-06-30 $165k 37k 4.41

More positions owned by Mirae Asset Global Etfs Holdings

NVIDIA Corporation (NVDA)
Global X Fds X Russell 2000 E (RSSL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Cameco Corporation (CCJ)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Intuitive Surgical Com New (ISRG)
Netflix (NFLX)
Trane Technologies SHS (TT)
United Rentals (URI)
Eaton Corp SHS (ETN)

View all positions for Mirae Asset Global Etfs Holdings

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin